 |
 |

Neuronal Enzymatic Failure in Creutzfeldt-Jakob DiseaseA Familial Study
REINHARD L. FRIEDE, MD;
RUSSELL N. DeJONG, MD
Arch Neurol. 1964;10(2):181-195.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
The dementias of the Creutzfeldt-Jakob group have been the subject of much controversy since their first descriptions by Creutzfeldt2 in 1920 and Jakob18 in 1921. Their etiology and pathogenesis are unknown, and both the clinical and morphological manifestations have often been under debate. In that member of the group usually referred to as Creutzfeldt-Jakob disease, the most characteristic clinical picture is that of a rapidly progressing intellectual deterioration, having its onset in the middle decades of life, and accompanied by signs of involvement of the extrapyramidal and pyramidal motor systems, and sometimes of the lower motor neurones. There may be hyperkinetic manifestations, often of a myoclonic type, along with spasticity and rigidity. The average duration of the disease is about 12 months. Pathologically, there are cytological alterations, cell loss, and status spongiosus affecting primarily the cerebral cortex, caudate nucleus, putamen, and anterior columns of the spinal cord, with
. . . [Full Text PDF of this Article]
Author Affiliations
ANN ARBOR, MICH
Mental Health Research Institute, Departments of Pathology and Neurology, The University of Michigan.
Footnotes
Submitted for publication May 30, 1963; accepted Sept 28.
Read at the 88th Annual Meeting of the American Neurological Association, Atlantic City, NJ, June 10-12, 1963.
This investigation was partly supported by US Public Health Service grant B-3250.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|